In order to directly evaluate the contribution of BT-IC to chemotherapeutic response, we isolated primary cancer cells from the biopsies of 26 breast cancer patients obtained prior to chemotherapy and correlated ALDH1 enzymatic activity, CD44+/CD24− phenotype and mammosphere forming rate with the efficacy of chemotherapy. The gene discussed is ALDH1A1; the disease is breast carcinoma.